Results 11 to 20 of about 407,552 (296)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE

open access: yesВопросы современной педиатрии, 2015
Modern successful treatment of rheumatic diseases is impossible without the use of intravenous immunoglobulin. The use of intravenous immunoglobulin is based on strict indications developed as a result of long-term multicenter controlled studies.
E. I. Alexeeva   +2 more
doaj   +2 more sources

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience [PDF]

open access: yesJRSM Open, 2018
Objectives The treatments of limbic and other autoimmune encephalitis include immunosuppression, symptomatic treatment, and in the case of paraneoplastic syndromes, appropriate therapy for underlying neoplasms.
JA Kinsella   +7 more
doaj   +3 more sources

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE

open access: yesПедиатрическая фармакология, 2013
The article gives data on the structure and function of immunoglobulins. Given the multitude of mechanisms of their action, indications to their use are constantly expanding.
T. V. Latysheva, E. A. Latysheva
doaj   +2 more sources

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy [PDF]

open access: yes, 2022
Intravenous immunoglobulins are an efficacious treatment for chronic inflammatory demyelinating polyradiculoneuropathy. Biomarkers for disease activity are lacking, making the need for ongoing treatment difficult to assess, leading to potential ...
van Doorn, P.A.   +20 more
core   +3 more sources

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS [PDF]

open access: yesJournal of IMAB, 2016
Intravenous immunoglobulin (IVIG) is a blood product prepared from the serum of of a thousand or more blood donors. The IVIG that is available contains complete immunoglobulin G( IgG )molecules which has intact Fc-dependent effector functions.
Lidija Kareva
doaj   +1 more source

Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG). [PDF]

open access: yes, 2020
Granulocytes are key effector cells of the innate immune system that cause substantial by-stander tissue damage in a broad range of inflammatory disorders.
Simon, Hans-Uwe   +2 more
core   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

open access: yes, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
Matthew Buckland (589995)   +27 more
core   +2 more sources

Intravenous immunoglobulins for epilepsy [PDF]

open access: yesCochrane Database of Systematic Reviews, 2010
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. People with epilepsy may present with various types of immunological abnormalities, such as low serum immunoglobulin A (IgA) levels, lack of the immunoglobulin G (IgG) subclass and identification of certain types of antibodies. Intravenous immunoglobulin
Jinsong, Geng   +6 more
openaire   +5 more sources

Intravenous immunoglobulin treatment in children with PANS/PANDAS conditions [PDF]

open access: yes, 2021
Key messages: PANS (Pediatric Acute onset Neuropsychiatric Syndrome)/PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infections) is described as an abrupt, dramatic onset of obsessive-compulsive disorder (OCD) or ...
Grøvan, Anette Olsson   +1 more
core   +1 more source

Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Introduction Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited.
Emin Abdullayev   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy